PIK3CA Mutation: A Key to Improved Colon Cancer Outcomes
A recent clinical trial, CALGB/SWOG 80702 (Alliance), has shed light on a potential new treatment strategy for patients with stage III colon cancer and a specific genetic mutation....
Read →Latest Health news and analysis from healthHQ.
A recent clinical trial, CALGB/SWOG 80702 (Alliance), has shed light on a potential new treatment strategy for patients with stage III colon cancer and a specific genetic mutation....
Read →We use cookies
We use essential cookies to run this site and optional cookies to understand usage and improve your experience. Read our Cookie Policy.
Choose which cookies you allow. Essential cookies are always active because the site needs them to function.
Required for the site to work, including security, forms, and remembering your consent choice.
Help us understand how visitors use the site so we can improve content and performance.
Used to personalize content and measure campaign effectiveness.